Reward for fight against onchocerciasis

November 06, 2006

The Managing Director of the Centre for Eye Research Australia, Prof Hugh Taylor AC, has been awarded the 2006 Mectizan Award, in recognition of his contributions and sustained dedication to the fight against onchocerciasis.

Prof Taylor is the first Australian recipient of the Award, announced at the Mectizan Expert Committee / Albendazole Coordination meeting in Atlanta, Georgia. The award was announced by the Mectizan Expert Committee on behalf of the Merck Mectizan Donation Program.

Onchocerciasis, or river blindness, is the world's second leading infectious cause of blindness. It is estimated about 18 million people are effected, mostly in Africa and south-America.

"I am grateful for this award in recognition of my contribution together with medical research partners in the field, in the past 30 years," Prof Taylor said.

The Centre for Eye Research Australia works toward the elimination of preventable vision loss and blindness - researching the causes, treatment and prevention of eye diseases.

The Mectizan Donation Program was established in 1988 to provide medical, technical and administrative oversight of the donation of Mectizan by Merck & Co., Inc. for the treatment of onchocerciasis.

Research Australia

Related Blindness Articles from Brightsurf:

New eye drops may prevent a common cause of blindness
New eye drops could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults, a study by Columbia University researchers has found.

Scientists pinpoint brain coordinates for face blindness
Danish and Norwegian researchers have moved one step closer to understanding where face blindness stems from in the brain.

Protein closely linked to commonest cause of blindness
An international team of scientists has identified a protein which is strongly linked to the commonest cause of blindness in developed countries when its levels are raised in the blood.

New glaucoma test to help prevent blindness
Researchers have identified 107 genes that increase a person's risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at risk of going blind from it.

Treatments for leading cause of blindness generate $0.9 to $3 billion
A new economic study, published in JAMA Ophthalmology and conducted by USC researchers at the Schaeffer Center for Health Policy & Economics, the Ginsburg Institute for Biomedical Therapeutics, and the Roski Eye Institute, quantifies the benefits of treatment for wAMD.

Identifying a gene for canine night blindness
An international team of researchers led by the University of Pennsylvania's Keiko Miyadera has identified the gene mutation responsible for a form of night blindness in dogs.

Poor diet can lead to blindness
An extreme case of 'fussy' or 'picky' eating caused a young patient's blindness, according to a new case report published today [2 Sep 2019] in Annals of Internal Medicine.

Brighter possibilities for treating blindness
Advances in preclinical research are now being translated into innovative clinical solutions for blindness, a review published in the 10th anniversary series of science Translational Medicine depicts.

How blindness shapes sound processing
Adults who lost their vision at an early age have more refined auditory cortex responses to simple sounds than sighted individuals, according to new neuroimaging research published in JNeurosci.

Study identifies new genes associated with the leading cause of blindness
A new study, published in Clinical Epigenetics, identifies genes associated with Age-related Macular Degeneration (AMD) that could represent new targets for future drug development.

Read More: Blindness News and Blindness Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to